In our previous laboratory investigations, we have observed that the combination therapy of NAC and insulin exhibits superior efficacy in managing various complications associated with T1DM, including cardiomyopathy, hepatic disorders, and renal dysfunction when compared to insulin monotherapy [24,25,26]. This evidence concerns the gene INS and liver disorder.